MIRA INFORM REPORT

 

 

Report Date :

14.09.2007

 

IDENTIFICATION DETAILS

 

Name :

DINESH REMEDIES LIMITED

 

 

Registered Office :

Shri Dinesh Mills Premises, Padra Road, Vadodara – 390 005, Gujarat

 

 

Country :

India

 

 

Financials (as on) :

31.03.2007

 

 

Date of Incorporation :

09.02.2005

 

 

Com. Reg. No.:

045447

 

 

CIN No.:

[Company Identification No.]

U24230GJ2005PLC045447

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

BRDD01134A

 

 

Legal Form :

A Public Limited Liability Company. Company’s shares are listed on Stock Exchanges.

 

 

Line of Business :

Manufacturers of Hard Gelatin Capsules shells.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 600000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow

 

 

Litigation :

Clear

 

 

Comments :

Subject is an old and established company having moderate track records. Company’s profitability is under severe pressure. It has some accumulated losses. Payments are reported as slow but correct.

 

The company can be considered normal for small business dealings at usual trade terms and conditions.

 

 

LOCATIONS

 

Registered Office :

Shri Dinesh Mills Premises, Padra Road, Vadodara – 390 005, Gujarat, India

E-Mail :

drl@dineshmills.com

Tel. No.:

91 – 265 – 2330060 To 2330065

Fax No.:

91 – 265 – 2336195

 

 

DIRECTORS

 

Name :

Mr. Upendrabhai M Patel

Designation :

Chairman And Managing Director

Date of Birth/Age :

76 years

Qualification :

B.Sc. (Hons.), Mumbai; MBA (USA)

Experience :

52 years

 

 

Name :

Mr. Bharatbhai U Patel

Designation :

Managing Director

Date of Birth/Age :

50 years

Qualification :

B. Text., MBA (USA)

Experience :

30 years

Date of Appointment :

12.05.1973

 

 

Name :

Mr. R C Patel

Designation :

Additional Director

 

 

Name :

Mr. Manish C. Patel

Designation :

Additional Director

 

 

Name :

Mr. Hasmukhbhai Patel

Designation :

Additional  Director

 

 

Name :

Mr. Sanjeev Shah

Designation :

Additional  Director

 

 

KEY EXECUTIVES

 

Name :

Mr. Chirag Shukla

Designation :

Company Secretary

 

 

 

 

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturers of Hard Gelatin Capsules shells.

 

 

Products :

Item Code No.

Product Description

96020030

Empty Hard Gelatin Capsule

 

PRODUCTION STATUS

 

Products

 

Unit

Installed Capacity

Actual Production

Empty Hard Gelatin Capsule

 

Nos.

1750.000 Millions

140.978

Millions

 

Note: Company has filed memorandum of manufacture for 1750.000 Millions Nos. of capsules with SIA, Ministry of Commerce and Industry, Government of India

 

 

GENERAL INFORMATION

 

Bankers :

Ř       Bank of Baroda

Ř       Central Bank of India

Ř       Indian Overseas Bank

 

 

Facilities :

Secured Loans

As on 31.03.2007

Rs. in Millions

Term Loan, secured by Exclusive charge on Fixed Assets including Equitable mortgage on Free-hold Land

55.500

Total

55.500

 

 

 

Banking Relations :

Satisfactory

 

 

Auditors :

 

Name :

Dalal and Shah

Chartered Accountants

Address :

Mumbai, Maharashtra, India

Tel. No.:

91-79-26576161

Fax No.:

91-79-26576262

 

 

Holding Company:

Shri. Dinesh Mills Limited

 

 

Associates/Subsidiaries :

Ř       Dinesh Platechem Limited

            Address: Padra Road, Baroda, Gujarat, India

            Line of Business :  Electroplating Chemicals

Ř       Dinesh Petrochemicals Limited

Ř       Dinesh Machines Limited

Ř       Dinesh Draka Optical Fibre Limited

Ř       McGean Rohco Dinesh Limited

 

 

 

 

 

 

 

CAPITAL STRUCTURE

 

Authorised Capital :

No. of Shares

Type

Value

Amount

15000000

Equity Shares

Rs. 10.00 each

Rs. 150.000 millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

15000000

Equity Shares

Rs. 10.00 each

Rs. 150.000 millions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2007

31.03.2006

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

150.000

91.000

2] Share Application Money

 

0.000

0.000

3] Reserves & Surplus

 

0.000

0.000

4] (Accumulated Losses)

 

0.000

0.000

NETWORTH

 

150.000

91.000

LOAN FUNDS

 

 

 

1] Secured Loans

 

55.500

0.000

2] Unsecured Loans

 

0.000

0.000

TOTAL BORROWING

 

55.500

0.000

DEFERRED TAX LIABILITIES

 

0.000

0.000

 

 

 

 

TOTAL

 

205.500

91.000

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

162.427

6.094

Capital work-in-progress

 

0.000

0.000

 

 

 

 

INVESTMENT

 

0.000

12.797

DEFERREX TAX ASSETS

 

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 

8.546

0.000

 

Sundry Debtors

 

0.918

0.000

 

Cash & Bank Balances

 

17.862

36.078

 

Other Current Assets

 

0.000

0.000

 

Loans & Advances

 

14.176

1.586

Total Current Assets

 

41.501

37.665

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Current Liabilities

 

11.097

2.067

 

Provisions

 

0.163

0.316

Total Current Liabilities

 

11.259

2.383

Net Current Assets

 

30.241

35.282

 

 

 

 

MISCELLANEOUS EXPENSES

 

12.832

2.299

 

 

 

 

TOTAL

 

205.500

91.000

 

 

 

 

 

 

 

 

 

 

 

 

 

PROFIT & LOSS ACCOUNT

 

PARTICULARS

 

 

31.03.2007

31.03.2006

Sales Turnover

 

1.258

1.179

Other Income

 

1.169

0.000

Increase / (Decrease) in stocks

 

5.441

0.000

Total Income

 

7.869

1.179

 

 

 

 

Profit/(Loss) Before Tax

 

(10.638)

(1.668)

Provision for Taxation

 

0..085

0.440

Profit/(Loss) After Tax

 

(10.723)

(2.108)

 

 

 

 

Import Value

 

52.155

0.000

 

 

 

 

Expenditures :

 

 

 

 

Materials

 

3.339

0.000

 

Manufacturing Expenses

 

5.197

0.041

 

Employees’ Emoluments

 

5.471

1.173

 

Interest

 

0.652

0.000

 

Selling and other expenses

 

4.218

4.763

 

Depreciation

 

2.809

0.014

 

Pre-operative expenses

 

3.179

3.143

Total Expenditure

 

24.865

9.134

 

 

KEY RATIOS

 

PARTICULARS

 

 

 

31.03.2007

31.03.2006

PAT / Total Income

(%)

 

(136.27)

(178.80)

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

 

(845.63)

(141.48)

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

 

(5.22)

(3.81)

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

 

(0.07)

(0.02)

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

 

0.45

0.03

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

 

3.69

15.81

 

 

 

 

 

 

 

 

 

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Fixed Assets

 

*       Freehold Land

*       Buildings

*       Tubewell

*       Plant and Machinery

*       Electrical Installations

*       Furniture

*       Dead Stock

*       Vehicles

 

Present Status of the Company

 

During the year under review, the Company has started manufacturing of Hard Gelatin capsule shells I P w.e.f. 21.11.2006 after obtaining all statutory permissions, Registrations and licenses with installation of two capsule manufacturing machines at the total project cost of Rs. 257.500 millions. As the Hard Gelatin capsule shells, I P being manufactured are to be approved by customers during the year 2006-07 and therefore, the company could sell Hard Gelatin capsule shells, I P only amounting to Rs. 1.500 millions.

 

The Company has recently imported further two capsule manufacturing machines which are under installation.

 

Barring unforeseen circumstances, members of the Board of Directors of the company are hopeful to stabilize the quality production of hard Gelatin capsule shells I P during the year 2007-08 with four capsule manufacturing machines.

 

Future Outlook

 

The Pharma Sector is growing and they have planned to cater initially Domestic MNC within a year. They are also planning to export the Capsules after getting USFDA approval, WHOGMP and DMF Registration so as to get better rates and price realization.

 

 

Contingent Liability not provided for: (As on 31.03.2006)

 

Guarantees given by the company’s Bankers – Rs. 1.517 Millions

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 40.44

UK Pound

1

Rs. 82.01

Euro

1

Rs. 56.20

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

3

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

2

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

3

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

28

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions